Table of Contents
1. INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2. RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3. MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4. MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL SKIN GRAFT MARKET, BY GRAFT TYPE
5.1 AUTOLOGOUS
5.2 ISOGENEIC
5.3 ALLOGENEIC
5.4 XENOGENEIC
5.5 PROSTHETIC
6. GLOBAL SKIN GRAFT MARKET, BY GRAFT THICKNESS
6.1 SPLIT-THICKNESS
6.2 FULL-THICKNESS
6.3 COMPOSITE GRAFT
7. GLOBAL SKIN GRAFT MARKET, BY APPLICATIONS
7.1 EXTENSIVE WOUND
7.2 BURNS
7.3 EXTENSIVE SKIN LOSS DUE TO INFECTION
7.4 SKIN CANCERS
7.5 OTHERS
8. GLOBAL SKIN GRAFT MARKET, BY EQUIPMENT
8.1 DERMATOME
8.1.1 KNIVES DERMATOMES
8.1.2 DRUM DERMATOMES
8.1.3 ELECTRIC DERMATOMES
8.1.4 AIR DERMATOMES
8.2 GENERAL SURGICAL INSTRUMENTS
8.3 CONSUMABLES
8.4 OTHERS
9. GLOBAL SKIN GRAFT MARKET, BY END USERS
9.1 HOSPITALS AND CLINICS
9.2 ACADEMIC AND RESEARCH
9.3 OTHERS
10. GLOBAL SKIN GRAFT MARKET, BY REGION
10.1 NORTH AMERICA
10.1.1 INTRODUCTION
10.2 EUROPE
10.2.1 INTRODUCTION
10.3 ASIA-PACIFIC
10.3.1 INTRODUCTION
10.4 MIDDLE EAST & AFRICA
10.4.1 INTRODUCTION
11. COMPETITIVE LANDSCAPE
11.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
11.1.1 STRATEGIC PARTNERSHIP
11.1.2 MERGER & ACQUISITION
12. COMPANY PROFILE
12.1 ORGANOGENESIS, INC.
12.1.1 OVERVIEW
12.1.2 PRODUCT OVERVIEW
12.1.3 FINANCIALS
12.1.4 KEY DEVELOPMENTS
12.2 SPECMED
12.2.1 OVERVIEW
12.2.2 PRODUCT OVERVIEW
12.2.3 FINANCIALS
12.2.4 KEY DEVELOPMENTS
12.3 STRATATECH CORP.
12.3.1 OVERVIEW
12.3.2 PRODUCT OVERVIEW
12.3.3 FINANCIALS
12.3.4 KEY DEVELOPMENT
12.4 TISSUE REGENIX GROUP PLC
12.4.1 OVERVIEW
12.4.2 PRODUCT OVERVIEW
12.4.3 FINANCIALS
12.4.4 KEY DEVELOPMENTS
12.5 AVITA MEDICAL
12.5.1 OVERVIEW
12.5.2 PRODUCT OVERVIEW
12.5.3 FINANCIALS
12.5.4 KEY DEVELOPMENTS
12.6 CONVATEC INC
12.6.1 OVERVIEW
12.6.2 PRODUCT OVERVIEW
12.6.3 FINANCIALS
12.6.4 KEY DEVELOPMENTS
12.7 MEDROTONIC
12.7.1 OVERVIEW
12.7.2 PRODUCT OVERVIEW
12.7.3 FINANCIALS
12.7.4 KEY DEVELOPMENTS
12.8 COLOPLAST
12.8.1 OVERVIEW
12.8.2 PRODUCT OVERVIEW
12.8.3 FINANCIALS
12.8.4 KEY DEVELOPMENTS
12.9 B.BRAUN MELSUNGEN
12.9.1 OVERVIEW
12.9.2 PRODUCT OVERVIEW
12.9.3 FINANCIALS
12.9.4 KEY DEVELOPMENTS
12.10 ZIMMERBIOMET
12.12.1 OVERVIEW
12.12.2 PRODUCT OVERVIEW
12.12.3 FINANCIALS
12.12.4 KEY DEVELOPMENTS
12.11 OTHERS
13. CONCLUSION
13.1 KEY FINDINGS
13.1.1 FROM CEO’S VIEWPOINT
13.1.2 UNMET NEEDS OF THE MARKET
13.2 KEY COMPANIES TO WATCH
13.3 PREDICTION OF SKIN GRAFT INDUSTRY
14. APPENDIX
